查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1985734

生物检体处理市场：全球市场预测（按产品类型、工作流程、检体类型、应用和最终用户划分），2026-2032年

Biological Sample Handling Market by Product Type, Workflow, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物样本处理市场价值将达到 210.9 亿美元，到 2026 年将成长至 224.2 亿美元，到 2032 年将达到 331.6 亿美元，复合年增长率为 6.67%。

主要市场统计数据
基准年 2025 210.9亿美元
预计年份：2026年 224.2亿美元
预测年份 2032 331.6亿美元
复合年增长率 (%) 6.67%

透过明确营运重点、品质压力以及跨职能决策的必要性，我们为生物检体处理建立了策略背景。

现代生物检体处理体系处于科学严谨性、营运效率和严格法律规范三者交会的十字路口。实验室、临床机构、研究中心和工业研发团队面临着从样本采集到检体全程维护检体完整性的日益增长的要求。儘管自动化、数位化和试剂化学的进步正在改变日常工作流程，但对可重复性和可追溯性的不断提高的期望要求更严格的流程控制和检验的供应链。

整体情况了将透过自动化、试剂创新和数据驱动的储存历史管理解决方案重塑检体处理的变革性变化。

生物检体处理领域正经历一场变革，其驱动力包括技术的成熟、监管机构对资料完整性的重视，以及临床和科学研究终端使用者不断变化的需求。自动化正从单一仪器发展到整合的工作流程平台，这些平台整合了样本采集、处理和储存功能，使实验室能够在扩大处理能力的同时减少人为错误。试剂配方和试剂盒设计的同步进步提高了不同检测方法之间的稳定性和相容性，从而降低了变异性并缩短了验证週期。

评估 2025 年推出的关税措施对检查室采购、供应商策略和供应链韧性的累积营运和采购影响。

2025年实施的新关税措施增加了全球生物检体处理供应链的复杂性，影响了筹资策略和营运规划。进口检测设备、耗材和某些试剂类别的关税调整增加了依赖跨境采购的机构的接收成本，迫使采购团队重新评估供应商选择和库存策略。为此，许多机构正在重新计算其总拥有成本（TCO），以反映关税、更长的前置作业时间和增加的物流风险。

透过整合产品、最终用户、应用、检体类型和工作流程因素来确定采购和验证的优先事项，我们提供可操作的细分见解。

对市场区隔的详细分析揭示了产品类型、最终用户、应用、样本类型和工作流程如何影响整个样本处理过程中的采购优先顺序和创新应用。对产品类型的检验表明，耗材、仪器、试剂/试剂盒和软体/服务各自为买家提供不同的价值提案。在仪器领域，由于实验室寻求更高的处理能力和可重复性，对自动移液系统、温控离心机和涡旋混合器的需求尤其强劲。同时，抗体、缓衝液/溶液、酵素和标记/检测试剂等试剂和试剂盒对检测性能和相容性有显着影响。最终用户的多样性影响着采购行为。学术和研究机构、生物製药公司、受託研究机构(CRO)、诊断检查室和医院在验证、处理能力和成本控制方面采用不同的标准。特别是诊断检查室，又细分为临床化学、血液学、微生物学和分子诊断，每个实验室都有其独特的处理要求。

本文说明了区域管理体制、製造能力和物流基础设施如何为美洲、欧洲、中东和非洲以及亚太地区创造不同的机会。

随着各组织评估区域法规结构、製造地和物流基础设施，区域趋势正在影响检体处理的策略选择。在美洲，需求模式反映了高通量临床检查室中心和生物製药研发机构的广泛需求，这些机构优先考虑自动化、长期供应商关係以及快速获取新型试剂。供应链整合和主要合约服务供应商的存在进一步影响供应商的选择和首选的经营模式。

在预处理阶段，透过结合检验的产品系列、服务模式和互通性，识别供应商之间的竞争差异化因素，以减少变异性。

在检体处理生态系统中，竞争格局日益取决于企业提供涵盖硬体、耗材、试剂和资讯服务的一体化提案主张的能力。拥有完善的品质系统、法规支援和清晰检验文件的供应商通常更受受监管的终端用户青睐。同时，拥有模组化和互通平台的供应商则更受高通量研究机构和工业客户的青睐。投资于特定应用试剂盒和试剂以及检验的通讯协定的企业，能够降低采用门槛并提高客户维繫，尤其是在诊断流程和受监管的药物开发工作流程中。

为领导者提供切实可行的建议，以加强供应链韧性、规范验证并扩大自动化，从而降低预分析和营运风险。

产业领导者可立即采取行动，透过协调筹资策略、合格计画和跨职能管治来提升检体处理效率。首先，应建立严格的供应商资格认证流程，评估批次间一致性文件、试剂稳定性数据和耗材可追溯性，并在合约中明确关税和物流风险。其次，应优先投资自动化系统，以显着减少人为错误并实现稳定的处理能力。同时，应实施培训计划，确保检查室人员能够有效操作和维护自动化系统。

为了确保实用和准确的见解，我们描述了一种严格的混合方法调查方法，该方法结合了初步访谈、技术文献综述和专家检验。

本研究途径结合了结构化的初步调查和有针对性的二次分析，旨在对生物检体处理动态进行稳健且基于证据的评估。初步数据包括对实验室经理、采购经理、品质保证负责人和供应链经理的访谈，以收集关于挑战、推广驱动因素和检验障碍的第一手观点。这些访谈旨在了解操作细节，例如工作流程瓶颈、试剂稳定性问题和仪器运转率优先级，并确保匿名性和保密性，以鼓励受访者坦诚作答。

最后，我们将清楚地总结如何透过对自动化、经验证的试剂和稳健的采购进行协调投资来确保检体完整性和营运连续性。

总而言之，生物检体处理产业正处于转折点，技术创新、监管和供应链趋势在此交汇，重新定义了检查室保护检体完整性和加速发现的方式。积极投资于可互通自动化系统、经过验证的试剂系统和即时监管链监控的机构，将更有能力管理分析前变异性和履行合规义务。同样重要的是，鑑于关税压力和物流不确定性，对采购惯例进行策略性重新评估，这将有助于供应商组合多元化和加强区域伙伴关係关係。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 生物检体处理市场：依产品类型划分

  • 消耗品
  • 装置
    • 自动移液系统
    • 温控离心分离器
    • 涡流混合器
  • 试剂和试剂盒
    • 抗体
    • 缓衝液和溶液
    • 酵素
    • 标记和检测试剂
  • 软体和服务

第九章 生物检体处理市场：依工作流程划分

  • 分析
  • 收藏
  • 预处理
  • 贮存
  • 运输

第十章：检体类型分類的生物检体处理市场

  • 血
  • 细胞
  • 组织
  • 尿

第十一章：生物检体处理市场：依应用领域划分

  • 诊断
    • 临床检测
    • 护理点
  • 药物发现与开发
  • 基因组学
  • 蛋白质体学

第十二章 生物检体处理市场：依最终用户划分

  • 学术研究机构
  • 生物製药公司
  • 合约研究机构
  • 诊断检查室
    • 临床化学
    • 血液学
    • 微生物学
    • 分子诊断
  • 医院

第十三章 生物检体处理市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：生物检体处理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 生物检体处理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国生物检体处理市场

第十七章：中国生物检体加工市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accelerated Laboratory Logistics
  • Alliance Pharma PLC
  • Azenta Life Sciences
  • BioDock Limited
  • BioLife Solutions Inc.
  • Clinigen Group
  • Cryoniss
  • Cryoport Systems, LLC
  • Discovery Life Sciences
  • Eppendorf SE
  • Hamilton Company
  • Infiuss Health
  • Labtoo
  • Marken by United Parcel Service, Inc.
  • Mercury Business Services
  • MLM Medical Labs
  • Oximio
  • PrecisionMed, LLC
  • ReproCELL Inc.
  • SAROUTE Co., Ltd.
  • SPT Labtech Ltd.
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market was valued at USD 21.09 billion in 2025 and is projected to grow to USD 22.42 billion in 2026, with a CAGR of 6.67%, reaching USD 33.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 21.09 billion
Estimated Year [2026] USD 22.42 billion
Forecast Year [2032] USD 33.16 billion
CAGR (%) 6.67%

Establishing the strategic context for biological sample handling by outlining operational priorities, quality pressures, and cross-functional decision imperatives

The contemporary ecosystem for biological sample handling sits at the intersection of scientific rigor, operational efficiency, and stringent regulatory oversight. Laboratories, clinical facilities, research centers, and industrial R&D teams face an expanding set of requirements to preserve sample integrity from collection through analysis. Advances in automation, digitization, and reagent chemistry are reshaping daily workflows, while heightened expectations around reproducibility and traceability demand tighter process controls and validated supply chains.

Against this backdrop, organizations must balance cost pressures with the imperative to minimize pre-analytical variability. Investments in instrumentation, consumables, and end-to-end workflow solutions increasingly reflect a strategic choice to reduce downstream assay failures and accelerate time to insight. As practices evolve, cross-functional collaboration among procurement, laboratory operations, quality, and informatics becomes vital to ensure that equipment selection, reagent sourcing, and storage protocols collectively support scientific objectives without introducing unmanageable complexity. This introduction frames the primary forces influencing decision-making and sets the stage for deeper analysis of technological shifts, policy impacts, and segmentation-specific dynamics that follow.

Mapping the transformative shifts reshaping sample handling through automation, reagent innovation, and data-driven chain-of-custody solutions

The landscape of biological sample handling is undergoing transformative shifts driven by technological maturation, regulatory emphasis on data integrity, and changing demand patterns from both clinical and research end users. Automation is moving beyond isolated instruments to integrated workflow platforms that combine collection, processing, and storage functions, enabling labs to scale throughput while reducing human error. Parallel advances in reagent formulations and kit design are improving stability and compatibility across diverse assay modalities, which in turn reduces variability and shortens validation timelines.

Data-centric approaches are becoming central; laboratory informatics systems and connected devices now enable real-time monitoring of sample chain-of-custody and environmental conditions. This connectivity supports risk-based quality management and allows organizations to detect and remediate deviations more quickly. Additionally, there is an increasing premium on modular solutions that can be configured to meet both high-throughput industrial needs and smaller, decentralized clinical settings. Taken together, these trends are reshaping procurement priorities, incentivizing scalable investments, and redefining the vendor landscape as suppliers compete to offer interoperable, validated systems that span multiple steps of the sample lifecycle.

Assessing the cumulative operational and sourcing impacts of tariff measures introduced in 2025 on laboratory procurement, supplier strategies, and supply chain resilience

The advent of new tariff measures in 2025 has introduced a layer of complexity to global supply chains that support biological sample handling, affecting procurement strategies and operational planning. Tariff adjustments on imported laboratory equipment, consumables, and certain reagent categories have increased landed costs for organizations that rely on cross-border sourcing, prompting procurement teams to re-evaluate supplier selection and inventory policies. In response, many organizations are revisiting total cost of ownership calculations to reflect duties, longer lead times, and elevated logistics risk.

Consequently, buyers are exploring alternatives such as nearshoring, supplier diversification, and longer-term contracts to mitigate exposure to tariff volatility. These approaches generally emphasize building relationships with regional manufacturers and distributors, qualifying secondary suppliers to maintain continuity, and increasing buffer inventories for critical items. Regulatory-driven requirements for validated supply chains and traceability further complicate substitution decisions, creating tension between cost mitigation and compliance. Overall, the cumulative impact of the tariffs is accelerating strategic shifts toward more resilient sourcing models, greater supply chain transparency, and heightened collaboration between procurement and laboratory operations to balance affordability with uninterrupted access to validated materials and equipment.

Delivering practical segmentation insights by synthesizing product, end user, application, sample type, and workflow drivers that determine procurement and validation priorities

A nuanced view of segmentation reveals how product type, end user, application, sample type, and workflow each shape procurement priorities and innovation adoption across the sample handling continuum. Examining product type shows that consumables, instruments, reagents and kits, and software and services occupy distinct value propositions to buyers; within instruments there is a pronounced demand for automated pipetting systems, temperature-controlled centrifuges, and vortex mixers as laboratories seek throughput gains and reproducibility, while reagents and kits such as antibodies, buffers and solutions, enzymes, and labeling and detection reagents drive assay performance and compatibility. End user diversity affects purchasing behavior, as academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals each apply different standards for validation, throughput, and cost control, and diagnostic laboratories in particular subdivide into clinical chemistry, hematology, microbiology, and molecular diagnostics, each with its own handling requirements.

Application-level distinctions between diagnostics, drug discovery and development, genomics, and proteomics direct investments toward tailored solutions; diagnostics further differentiates along laboratory diagnostics and point-of-care pathways, where portability and stability become pivotal. Sample type considerations, encompassing blood, cells, tissue, and urine, impose varying constraints on collection devices, preservatives, storage temperatures, and transport logistics. Finally, the workflow segmentation across analysis, collection, processing, storage, and transport underscores the need for interoperable solutions that preserve pre-analytical integrity. These overlapping segmentations demonstrate that decisions about product selection and process design must be made in the context of specific end-use cases and operational constraints to achieve both scientific rigor and economic efficiency.

Explaining how regional regulatory regimes, manufacturing capacity, and logistical infrastructure create differentiated opportunities across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping strategic choices in sample handling as organizations weigh local regulatory frameworks, manufacturing footprints, and logistical infrastructure. In the Americas, demand patterns reflect a broad mix of high-throughput clinical laboratories, translational research centers, and biopharmaceutical R&D hubs that prioritize automation, long-term supplier relationships, and rapid access to novel reagents. Supply chain integration and the presence of large contract service providers further influence vendor selection and preferred commercial models.

Across Europe, Middle East & Africa, the landscape is heterogeneous: robust regulatory regimes and centralized healthcare systems in several European markets drive strong emphasis on compliance and validated cold chain capabilities, while emerging markets within the region often focus on affordability, reagent stability at ambient temperatures, and solutions that enable decentralized testing. In Asia-Pacific, rapid investment in genomic and proteomic research, coupled with growing domestic manufacturing capacity, is accelerating adoption of both high-end instruments and localized consumable production. Collectively, these regional differences underscore the importance of tailoring go-to-market strategies, regulatory engagement, and supply chain architecture to local conditions rather than pursuing a uniform global approach.

Identifying competitive differentiators among suppliers that combine validated product portfolios, service models, and interoperability to reduce pre-analytical variability

Competitive dynamics in the sample handling ecosystem are increasingly defined by the ability of organizations to offer integrated value propositions that span hardware, consumables, reagents, and data services. Suppliers that combine robust quality systems, regulatory support, and clear documentation for validation typically gain preference among regulated end users, while those with modular, interoperable platforms appeal to high-throughput research and industrial customers. Companies that invest in application-specific kits and reagents, along with validated protocols, reduce adoption friction and improve customer retention, particularly in diagnostic pathways and regulated drug development workflows.

Service-oriented business models, including instrument-as-a-service, reagent subscription programs, and remote monitoring, are emerging as differentiators that lower upfront capital barriers and provide predictable operational expenditure profiles. Strategic partnerships between instrument manufacturers and reagent suppliers, as well as collaborations with informatics vendors, are enabling more complete solutions that address pre-analytical variability. For procurement leaders, preferred suppliers are those that combine technical reliability, transparent quality practices, and agility in adapting to localized compliance requirements and logistical constraints.

Actionable recommendations for leaders to strengthen supply resilience, standardize validation, and scale automation to reduce pre-analytical risk and operational exposure

Industry leaders can take immediate, actionable steps to fortify sample handling operations by aligning procurement strategy, validation planning, and cross-functional governance. First, embed rigorous supplier qualification processes that evaluate documentation for lot-to-lot consistency, stability data for reagents, and traceability for consumables, while ensuring that contracts address tariff and logistics risks. Second, prioritize investments in automation where it demonstrably reduces manual error and enables consistent throughput; pair these investments with training programs that equip laboratory staff to operate and maintain automated systems effectively.

Third, adopt a risk-based approach to inventory and sourcing that blends regional supplier diversification with strategic onshore or nearshore partnerships to mitigate tariff exposure and lead time variability. Fourth, integrate environmental and chain-of-custody monitoring into laboratory informatics to provide real-time visibility into storage and transport conditions, supporting faster corrective actions and audit readiness. Finally, cultivate cross-functional steering committees composed of procurement, quality, laboratory operations, and R&D to oversee validation protocols, change controls, and supplier performance metrics. These measures collectively improve sample integrity, reduce operational disruptions, and create clearer pathways for scaling scientific operations responsibly.

Explaining a rigorous mixed-methods research methodology that integrates primary interviews, technical literature review, and expert validation to ensure actionable and accurate findings

The research approach combines structured primary engagement with targeted secondary analysis to produce a robust, evidence-based assessment of biological sample handling dynamics. Primary inputs include interviews with laboratory directors, procurement leads, quality assurance professionals, and supply chain managers to capture firsthand perspectives on pain points, adoption drivers, and validation hurdles. These conversations are framed to elicit operational details such as workflow bottlenecks, reagent stability concerns, and instrumentation uptime priorities while ensuring anonymity and confidentiality to promote candid responses.

Secondary research involves systematic review of technical literature, regulatory guidance, product documentation, and case studies to triangulate findings and test hypothesis robustness. Data synthesis emphasizes cross-validation across sources and stress-tests scenario assumptions to identify risks and opportunity levers. Where applicable, expert panels composed of experienced laboratorians and industry technologists review drafts to ensure practical relevance and technical accuracy. Finally, the methodology applies rigorous quality checks for internal consistency, logical coherence, and alignment with the latest published standards to ensure that conclusions are actionable and reflective of current operational realities.

Concluding with a clear synthesis of how coordinated investments in automation, validated reagents, and resilient sourcing secure sample integrity and operational continuity

In summary, the biological sample handling domain is at an inflection point where technological innovation, regulatory scrutiny, and supply chain dynamics converge to redefine how laboratories protect sample integrity and accelerate discovery. Organizations that proactively invest in interoperable automation, validated reagent systems, and real-time chain-of-custody monitoring will be better positioned to manage pre-analytical variability and compliance obligations. Equally important is the strategic reorientation of sourcing practices in light of tariff pressures and logistics uncertainties, which favors diversified supplier portfolios and stronger regional partnerships.

Taken together, these developments imply that operational excellence in sample handling is achieved not by isolated purchases but by coordinated programs that align procurement, quality, and laboratory operations around shared performance metrics. Leadership that fosters cross-functional governance, invests in staff capability, and prioritizes modular, validated solutions will capture the dual benefits of scientific reproducibility and operational resilience. The conclusion underscores the urgency for stakeholders to translate these insights into prioritized actions that protect scientific output and sustain organizational momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Handling Market, by Product Type

  • 8.1. Consumables
  • 8.2. Instruments
    • 8.2.1. Automated Pipetting Systems
    • 8.2.2. Temperature Controlled Centrifuges
    • 8.2.3. Vortex Mixers
  • 8.3. Reagents And Kits
    • 8.3.1. Antibodies
    • 8.3.2. Buffers And Solutions
    • 8.3.3. Enzymes
    • 8.3.4. Labeling And Detection Reagents
  • 8.4. Software And Services

9. Biological Sample Handling Market, by Workflow

  • 9.1. Analysis
  • 9.2. Collection
  • 9.3. Processing
  • 9.4. Storage
  • 9.5. Transport

10. Biological Sample Handling Market, by Sample Type

  • 10.1. Blood
  • 10.2. Cells
  • 10.3. Tissue
  • 10.4. Urine

11. Biological Sample Handling Market, by Application

  • 11.1. Diagnostics
    • 11.1.1. Laboratory Diagnostics
    • 11.1.2. Point Of Care
  • 11.2. Drug Discovery And Development
  • 11.3. Genomics
  • 11.4. Proteomics

12. Biological Sample Handling Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biopharmaceutical Companies
  • 12.3. Contract Research Organizations
  • 12.4. Diagnostic Laboratories
    • 12.4.1. Clinical Chemistry
    • 12.4.2. Hematology
    • 12.4.3. Microbiology
    • 12.4.4. Molecular Diagnostics
  • 12.5. Hospitals

13. Biological Sample Handling Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Sample Handling Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Sample Handling Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Sample Handling Market

17. China Biological Sample Handling Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accelerated Laboratory Logistics
  • 18.6. Alliance Pharma PLC
  • 18.7. Azenta Life Sciences
  • 18.8. BioDock Limited
  • 18.9. BioLife Solutions Inc.
  • 18.10. Clinigen Group
  • 18.11. Cryoniss
  • 18.12. Cryoport Systems, LLC
  • 18.13. Discovery Life Sciences
  • 18.14. Eppendorf SE
  • 18.15. Hamilton Company
  • 18.16. Infiuss Health
  • 18.17. Labtoo
  • 18.18. Marken by United Parcel Service, Inc.
  • 18.19. Mercury Business Services
  • 18.20. MLM Medical Labs
  • 18.21. Oximio
  • 18.22. PrecisionMed, LLC
  • 18.23. ReproCELL Inc.
  • 18.24. SAROUTE Co., Ltd.
  • 18.25. SPT Labtech Ltd.
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. Ziath Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)